Viewing Study NCT02275416


Ignite Creation Date: 2025-12-26 @ 11:48 AM
Ignite Modification Date: 2025-12-26 @ 11:48 AM
Study NCT ID: NCT02275416
Status: COMPLETED
Last Update Posted: 2024-12-16
First Post: 2014-09-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma
Sponsor: Ultimovacs ASA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module